NCT07596849 A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease. Status NOT_YET_RECRUITING Phase PHASE3
NCT07595653 A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy Status RECRUITING Phase N/A
NCT07583641 A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults Status NOT_YET_RECRUITING Phase PHASE2
NCT07570316 A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease Status NOT_YET_RECRUITING Phase PHASE3
NCT07377396 A Study to Assess the Safety of ARGX-124 in Healthy Volunteers Status RECRUITING Phase PHASE1
NCT07294170 ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis Status RECRUITING Phase N/A
NCT07287982 A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy Status RECRUITING Phase PHASE2
NCT07284420 ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod Status RECRUITING Phase PHASE2
NCT07264426 Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study Status RECRUITING Phase N/A
NCT07194850 A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) Status RECRUITING Phase PHASE2/PHASE3
NCT07091630 A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP Status RECRUITING Phase PHASE3
NCT07011589 Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06968338 A Study to Assess the Safety of ARGX-213 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT06920004 A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP Status RECRUITING Phase PHASE3
NCT06909214 A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG) Status RECRUITING Phase PHASE4
NCT06860633 Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod Status RECRUITING Phase PHASE4
NCT06799416 A Study to Assess the Safety of ARGX-109 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT06742190 A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06688253 Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis Status NOT_YET_RECRUITING Phase PHASE4